A detailed history of Courier Capital LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Courier Capital LLC holds 14,793 shares of ABBV stock, worth $2.71 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
14,793
Previous 16,606 10.92%
Holding current value
$2.71 Million
Previous $2.85 Million 2.56%
% of portfolio
0.2%
Previous 0.23%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$163.84 - $199.33 $297,041 - $361,385
-1,813 Reduced 10.92%
14,793 $2.92 Million
Q2 2024

Jul 23, 2024

SELL
$154.79 - $180.76 $172,281 - $201,185
-1,113 Reduced 6.28%
16,606 $2.85 Million
Q1 2024

Apr 15, 2024

SELL
$159.82 - $182.1 $194,181 - $221,251
-1,215 Reduced 6.42%
17,719 $3.23 Million
Q3 2023

Oct 13, 2023

SELL
$133.59 - $154.65 $224,030 - $259,348
-1,677 Reduced 8.14%
18,934 $2.82 Million
Q2 2023

Jul 31, 2023

BUY
$132.51 - $164.9 $181,538 - $225,913
1,370 Added 7.12%
20,611 $2.78 Million
Q1 2023

May 18, 2023

SELL
$144.61 - $166.54 $31,524 - $36,305
-218 Reduced 1.12%
19,241 $3.07 Million
Q4 2022

Jan 24, 2023

SELL
$138.31 - $165.87 $46,748 - $56,064
-338 Reduced 1.71%
19,459 $0
Q3 2022

Oct 18, 2022

SELL
$134.21 - $153.93 $2,684 - $3,078
-20 Reduced 0.1%
19,797 $2.66 Million
Q2 2022

Jul 20, 2022

SELL
$137.62 - $174.96 $80,507 - $102,351
-585 Reduced 2.87%
19,817 $3.04 Million
Q1 2022

May 02, 2022

SELL
$131.98 - $163.75 $190,051 - $235,800
-1,440 Reduced 6.59%
20,402 $3.31 Million
Q4 2021

Jan 18, 2022

SELL
$107.43 - $135.93 $140,625 - $177,932
-1,309 Reduced 5.65%
21,842 $2.96 Million
Q3 2021

Oct 14, 2021

SELL
$106.4 - $120.78 $1,915 - $2,174
-18 Reduced 0.08%
23,151 $2.5 Million
Q2 2021

Jul 12, 2021

BUY
$105.21 - $117.21 $12,204 - $13,596
116 Added 0.5%
23,169 $2.61 Million
Q1 2021

Apr 12, 2021

BUY
$102.3 - $112.62 $147,516 - $162,398
1,442 Added 6.67%
23,053 $2.5 Million
Q4 2020

Feb 10, 2021

BUY
$80.49 - $108.67 $23,261 - $31,405
289 Added 1.36%
21,611 $2.32 Million
Q3 2020

Nov 09, 2020

BUY
$85.91 - $100.83 $32,130 - $37,710
374 Added 1.79%
21,322 $1.98 Million
Q2 2020

Jul 06, 2020

BUY
$73.37 - $98.18 $136,981 - $183,302
1,867 Added 9.78%
20,948 $2.07 Million
Q1 2020

Apr 22, 2020

SELL
$64.5 - $97.79 $45,085 - $68,355
-699 Reduced 3.53%
19,081 $1.53 Million
Q4 2019

Jan 10, 2020

BUY
$72.13 - $90.25 $68,595 - $85,827
951 Added 5.05%
19,780 $1.78 Million
Q3 2019

Oct 04, 2019

BUY
$62.98 - $75.72 $1,322 - $1,590
21 Added 0.11%
18,829 $1.39 Million
Q2 2019

Jul 16, 2019

BUY
$65.7 - $83.98 $4,533 - $5,794
69 Added 0.37%
18,808 $1.37 Million
Q1 2019

Apr 25, 2019

BUY
$77.14 - $90.79 $73,437 - $86,432
952 Added 5.35%
18,739 $1.51 Million
Q4 2018

Feb 08, 2019

SELL
$77.85 - $96.01 $15,102 - $18,625
-194 Reduced 1.08%
17,787 $1.64 Million
Q3 2018

Oct 12, 2018

SELL
$88.91 - $98.84 $353,772 - $393,284
-3,979 Reduced 18.12%
17,981 $1.7 Million
Q2 2018

Jul 19, 2018

BUY
$89.78 - $106.23 $4,489 - $5,311
50 Added 0.23%
21,960 $2.04 Million
Q1 2018

Apr 27, 2018

SELL
$92.01 - $123.21 $67,075 - $89,820
-729 Reduced 3.22%
21,910 $2.07 Million
Q4 2017

Jan 25, 2018

SELL
$89.56 - $98.21 $13,344 - $14,633
-149 Reduced 0.65%
22,639 $2.19 Million
Q2 2017

Aug 10, 2017

BUY
N/A
22,788
22,788 $1.65 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $324B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Courier Capital LLC Portfolio

Follow Courier Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Courier Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Courier Capital LLC with notifications on news.